By Sheri Colberg, PhD
I recently co-chaired a new consensus statement from the American College of Sports Medicine (ACSM) that is an update from the 2010 joint ACSM/American Diabetes Association position statement on physical activity/exercise for individuals with type 2 diabetes (T2D). A lot more research has been conducted in the ensuing decade since the joint position statement was published, and this new consensus statement summarizes the current evidence.

Part 2 of this Q&A with our diabetes exercise expert covers pre-exercise glucose checks, exercise-induced hypoglycemia, and more.

By Sheri Colberg, PhD
Glucagon is such an important hormone when it comes to blood glucose management in everyone—and it both impacts and is impacted by type 1 diabetes (T1D). A recent mini-review in Physiological Reports focused on altered glucagon responses brought up some interesting points that are worth discussing further.

By Sheri Colberg, PhD
Who knew I'd be talking about carbohydrate intake and being active for the third time this year, but here we go again! Unfortunately, a lot of confusion still exists related to the practice known as "carb loading" as well.  Do you need to do it? Should you? How do you know?

By Sheri Colberg, PhD

The arrival of summer brings to mind visions of people having fun in the sun and recreating on the beach. Still, hotter weather also creates more significant risks related to dehydration and heat stress for people who are physically active outdoors. Aging by itself negatively affects the body's ability to dissipate heat in both dry and humid environments, but having diabetes further increases the risk of developing heat stress during outdoor activities, especially when hot and humid.

By Sheri Colberg, PhD
As the years have rolled by, nothing has become more apparent to me with each passing day than the fact that aging successfully requires a lot of work. When it comes to our bodies, nothing rings truer than "If you don't use it, you lose it." This is particularly true when it comes to preventing declines arising from disuse and when trying to slow down the normal impacts of aging.

By Sheri Colberg, PhD
Have you heard of TTP399? Despite its completely forgettable name used in clinical trials, this potential new oral medication may have the power to lower and stabilize blood glucose in people with type 1 diabetes (T1D). If approved, TTP399 (which would be given a spiffy new brand name) will be the first oral pill to treat T1D.

By Sheri Colberg, PhD
In late 2017, one of my columns addressed whether you can determine if your joint issues are related to being active, normal aging, or diabetes. The answer was that you really couldn't determine the exact cause(s), but any or all of them may be contributors. Does it matter more if you know the underlying cause if you can figure out the best treatment?

By Sheri Colberg, PhD
Ever since the US Diabetes Prevention Program (DPP) multicenter trial was completed nearly two decades ago, we have known that it is possible to prevent, or at least delay, prediabetes (an insulin-resistant state) from progressing into full-blown type 2 diabetes.

By Sheri Colberg, PhD
In the past, most elite athletes attempted to improve performance through strategies to achieve "high CHO availability," meaning building up adequate pre-exercise glycogen levels and carbohydrate intake during the competition to meet fuel needs, but more recently many have aimed instead for a strategy called "low CHO availability."